IL1B and neoplasm: Additionally, the NF-kB-inducing cytokines TNF, TL1A and IL-1β all promote Th9 cell differentiation and specifically enhance the anti-tumor efficacy of Th9 adoptive cellular therapy (ACT) (31–33, 61).